Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

24.91
BATS BZX Real-Time Price
As of 9:49am ET
 +0.33 / +1.34%
Today’s Change
21.84
Today|||52-Week Range
33.60
-0.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$788.7M

Company Description

Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products. With a primary focus on generic injectable pharmaceuticals, the company offers its customers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Sagent Pharmaceuticals was founded by Jeffrey M. Yordon on January 26, 2006 and is headquartered in Schaumburg, IL.

Contact Information

Sagent Pharmaceuticals, Inc.
1901 North Roselle Road
Schaumburg Illinois 60195
P:(847) 908-1600
Investor Relations:
(847) 908-1605

Employees

Shareholders

Individual stakeholders58.51%
Mutual fund holders46.64%
Other institutional27.78%

Top Executives

Michael LogerfoPresident, Secretary & Chief Legal Officer
Jonathon M. SingerChief Financial Officer & Executive Vice President
Jeffrey W. GreveVice President & Controller
Lorin DrakeVice President-Sales
Albert PattersonEVP-Corporate Development & National Accounts